Securities Fraud Investigation Into Acadia Healthcare Company, Inc. (ACHC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz has announced an investigation into Acadia Healthcare Company, Inc. (ACHC) for potential violations of federal securities laws. Following a disclosure of higher-than-expected expenses related to patient litigation, Acadia's stock price fell by 23% on December 3, 2025. Shareholders who lost money are urged to contact the law firm to potentially pursue a claim.

Acadia Healthcare Lowers 2025 Outlook on Higher Insurance Costs, BofA Says

Acadia Healthcare has lowered its 2025 adjusted EBITDA outlook due to rising insurance costs, according to BofA Securities. The company revised its guidance, reducing EBITDA to $601-$611 million and earnings forecast to $1.94-$2.04 per share. Liability costs are expected to rise significantly, impacting financial projections. BofA downgraded Acadia's stock to underperform, cutting its price target to $13. Shares fell nearly 13%.

BUZZ-Acadia Healthcare plunges after cutting 2025 profit forecast

Shares of Acadia Healthcarefall 23.53% to $12.60 in premarket tradingCo lowers forecast for 2025 adjusted EBITDA to between $601 million and $611 million, compared with its previous guidance of between $650 million and $660 millionEight of 14 brokerage rate the stock “buy” or higher, 5 “hold” and 1 “sell”; their median PT $22.50 - data compiled by LSEGAs of last close, ACHC down 58.41% YTD

Acadia Healthcare Stock (ACHC) Plunges on Guidance Cut

Acadia Healthcare (ACHC) stock dropped 22% after the company cut its full-year earnings guidance due to higher professional and general liability expenses. The company now expects 2025 adjusted EBITDA of $601-$611 million, down from $650-$660 million, and adjusted EPS of $1.94-$2.04, down from $2.35-$2.45. The increase in liability expenses was higher than expected, driven by higher settlement costs, increased claim frequency, and less favorable reinsurance terms. Despite this, Wall Street maintains a Moderate Buy rating on ACHC stock with a 55% upside potential.

Acadia Healthcare shares are trading lower after the company cut full-year 2025 guidance, updating its professional and general liability reserves due to larger expenses associated primarily with patient-related litigation.